MammaPrint the 70-gene signature – another milestone in personalized medical care for breast cancer patients.

Publication Name: Expert Review, Diagnostic Profile

Author(s): EA Slodkowska and JS Ross

The MammaPrint™ assay (Agendia BV, The Netherlands) is the first fully commercialized microarray-based multigene assay designed to individualize treatment for patients with breast cancer. MammaPrint, the first assay to be cleared at the 510(k) level by the US FDA’s new in … Continued